Clinical trial
Dialysis Clinical Outcomes Revisited (DCOR) Trial
NCT00324571 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00324571 |
|---|---|
| Title | Dialysis Clinical Outcomes Revisited (DCOR) Trial |
| Official title | A Randomized, Open Label, Parallel Design Study of Renagel® Phosphate Binder Versus Calcium-Based Phosphate Binders in Hemodialysis Patients |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Sevelamer hydrochloride, Calcium-based phosphate binder |
| Enrollment | 2,000 |
| Start date | Mar 1, 2001 |
| Completion | Feb 1, 2006 |
| First posted | May 11, 2006 |
| Last update posted | Mar 18, 2015 |
| Countries | Puerto Rico, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: